> ## Content Index
> Fetch the complete content index at: https://members.americanhealthintel.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Telix buys ITM Isotope Technologies for up to $2.35B after FDA rejection
- URL: https://members.americanhealthintel.com/2026-09-21-ledger/
- Published: 2026-09-21T22:50:32.000Z
- Updated: 2026-09-21T22:50:32.000Z
- Description: Plus: HCA Healthcare completes acquisition of 8,000-student health training college. The day's rules, money, and enforcement, sourced and tiered below.
- Author: American Health Intel

Plus: HCA Healthcare completes acquisition of 8,000-student health training college. The day's rules, money, and enforcement, sourced and tiered below.

| American Health Intel Rules · Money · Medicine · Decoded daily The Ledger Monday, September 21, 2026 Telix buys ITM Isotope Technologies for up to $2.35B after FDA rejection Plus: HCA Healthcare completes acquisition of 8,000-student health training college. The day's rules, money, and enforcement, sourced and tiered below. ![](https://americanhealthintel.com/email/pulse-divider.png) Record Telix Pharmaceuticals, a cancer radiopharmaceutical maker, is paying up to $2.35 billion for ITM, the isotope supplier whose lead cancer drug the FDA rejected six weeks ago over manufacturing, not the science. The deal is $1.65B upfront plus up to $700M in milestones. Telix shares fell as much as 12% as investors weighed new-share dilution against locking in ITM's isotope supply chain. Record HCA Healthcare, the largest for-profit hospital operator in the US, just became the owner of an 8,000-student healthcare training school instead of competing for scarce clinical staff. HCA closed its acquisition of The College of Health Care Professions Sept 15, a deal first agreed in May. Terms undisclosed. HCA already runs 3 nursing colleges and 365+ GME programs. Also today Ascension posts $1.5B net income in first full turnaround year [Read](https://americanhealthintel.com/editions/2026-09-21-ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#ascension-fy2026-turnaround-results) Advocate Health cancels 11,500 medical debt property liens [Read](https://americanhealthintel.com/editions/2026-09-21-ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#advocate-health-medical-debt-lien-cancellation) Omnicare's bankruptcy plan confirmed, closing $440M fraud settlement [Read](https://americanhealthintel.com/editions/2026-09-21-ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#cvs-omnicare-440-million-settlement) 714Records$38.5BEnforcement32Deadlines186Rules [Read this issue + the trackers](https://americanhealthintel.com/editions/2026-09-21-ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) Pick your field on the site and every story tells you what it means for you. Reply to this email and tell us what you want covered. We read everything. We show our work. We score our own calls. [Track record](https://americanhealthintel.com/ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [Calendar](https://americanhealthintel.com/calendar/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [Enforcement](https://americanhealthintel.com/enforcement/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [X](https://x.com/amhealthintel?ref=members.americanhealthintel.com) · [LinkedIn](https://www.linkedin.com/company/american-health-intel?ref=members.americanhealthintel.com) News and analysis, not legal, medical, coding, or investment advice.You subscribed at americanhealthintel.com · [Unsubscribe](%%{unsubscribe%5Furl}%%) |
| ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |